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Background: A study was conducted to evaluate and compare the effectiveness of two different spot-on topical
flea products to control flea infestations on naturally infested dogs and cats in Tampa, FL USA.
Methods: Thirty-two dogs and 3 cats with natural flea infestations living in 18 homes were treated topically with a
19.53% w/w spot-on formulation of indoxacarb. Another thirty dogs and 2 cats living in 19 different homes were
treated topically with either fipronil (9.8% w/w)/(s)-methoprene (8.89% w/w) or fipronil (9.8% w/w)/(s)-methoprene
(11.8% w/w), respectively. All products were applied according to label directions by study investigators on day 0
and again between days 28 and 30. Flea populations on pets were assessed using visual area counts and premise
flea infestations were assessed using intermittent-light flea traps on days 0, 7, 14, 21, 28–30, 40–45, and 54–60.
Results: A single application of the indoxacarb or fipronil (s)-methoprene formulations reduced flea populations on
pets by 97.8% and 85.5%, respectively within 7 days. One month (28–30 days) after treatment the indoxacarb and
fipronil (s)-methoprene formulations reduced on-animal flea burdens by 95.0% and 49.5%, respectively. Following
two monthly applications of either the indoxacarb or fipronil (s)-methoprene formulations, pet flea burdens were
reduced by 99.1% and 54.8%, respectively, by days 54 – 60. At the end of the two month study, 77.1% and 15.6% of
the dogs and cats in the indoxacarb and fipronil (s)-methoprene treatment groups, respectively were flea free. Flea
numbers in the indoor-premises were markedly reduced in both treatment groups by days 54–60, with 97.7% and
84.6% reductions in intermittent-light flea trap counts in the indoxacarb and fipronil (s)-methoprene treatment
groups, respectively.
Conclusions: This in-home investigation conducted during the summer of 2013 in subtropical Tampa, FL, is the first
published U.S field investigation of the indoxacarb topical formulation. The indoxacarb formulation was able to
effectively control flea populations in heavily flea infested pets and homes. The efficacy achieved by the fipronil
(s)-methoprene formulation against flea infestations on these pets was lower than in previous investigations using
the same study design.
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Fleas are likely the most common ectoparasite infesting
dogs and cats. Elimination and prevention of flea infesta-
tions are critical to maintaining good health because
fleas are not just irritating, but clinically relevant, caus-
ing anemia, being responsible for allergic dermatitis, vec-
toring various bacterial pathogens, and serving as the
intermediate host for filarid and cestode parasites in
dogs and cats [1].
Previous studies conducted in the United States, Europe
and Australia have demonstrated that dinotefuran-
pyriproxyfen, fipronil (±, (s)-methoprene) imidacloprid,
imidacloprid-flumethrin, lufenuron (+pyrethrin spray or +
nitenpyram tablets) selamectin, and spinosad were effect-
ive in markedly reducing or eliminating natural flea infes-
tations on dogs and cats and in private residences without
the need for treatment of the premises [2-10]. Flea infes-
tations were eliminated or dramatically reduced in
these studies by controlling flea reproduction by either
killing most newly acquired fleas prior to initiation of
egg laying and/or rendering the vast majority of de-
posited eggs non-viable. Since the introduction of the
modern topical and systemic products in the mid-
1990s it appears that flea control on pets and in their
owners’ homes succeeds or fails based upon a product
or combination of products’ ability to suppress flea
reproduction [6,7].
The objective of this current study was to evaluate the
performance of a new indoxacarb containing topical
spot-on formulation to eliminate natural flea infestations
on dogs and cats in Tampa, FL USA. Indoxacarb is con-
sidered a pro-insecticide that is bioactivated by esterase
and amidase enzymes within the insect to a more active
metabolite [11,12]. A previous laboratory study con-
ducted at Kansas State University demonstrated that a
single topical spot-on formulation of indoxacarb applied
to cats provided ≥99.6% efficacy against flea infestations
for 6 weeks [13]. This treatment also markedly reduced
or eliminated egg production for 45 days and reduced
the viability of the few eggs that were produced for up
to 38 days following a single treatment [13]. These la-
boratory data indicated that the formulation might be
able to effectively control flea populations in naturally
flea infested pets and their homes. The positive reference
control chosen for this study was fipronil (s)-metho-
prene. Both fipronil only and fipronil (s)-methoprene
topical spot-ons have been used previously in our studies
in Tampa with good results [4,6,7].
The effectiveness of the treatments was assessed using
both premises and on-animal flea population estimating
techniques. The study design used in this investigation
eliminated client and veterinarian perceptions of per-
formance and reduced client compliance problems be-
cause investigators administered products to all animals.Methods
Home and pet study inclusion criteria
Through referrals from Sunshine Animal Hospital, Tampa,
FL and advertisements on CRAIGSLIST®, 42 private resi-
dences were selected for inclusion in the study from May
21 - June 01, 2013.
Homes were selected based on the following criteria:
1) a minimum of five fleas observed in area flea counts
on at least one dog at the residence; 2) a minimum of
five fleas collected in a 16 – 24 hour period in two inter-
mittent light flea traps; 3) one to five healthy, non-
fractious dogs or cats at the residence; 4) qualifying pets
must spend the majority of their time in the indoor
premises; 5) homeowner’s willingness to participate in
the 2 month study; 6) owners agreeing not to use any
other topical or premise flea control products during the
study; 7) no dog or cat in the household can be pregnant
or nursing; 8) completion of a questionnaire concerning
pet habits, visiting pets, previous flea treatments and
personal observations around their residence concerning
wildlife and feral cats and 9) owners willingness to sign
an informed consent form.
All dogs and cats were client-owned, resided in a pri-
vate residence and were handled and treated in compli-
ance with Kansas State Institutional Animal Care and
Use Committee (IACUC #3281) approval.
Treatment groups
Homes and pets meeting these criteria were placed into
1 of 2 treatment groups. Home entry numbers (1–42)
were each assigned a random number by Excel (Excel
2010) and blocked into groups of 2. The highest random
number within each block was assigned to group 1 and
lowest to group 2.
Dogs and cats in treatment group 1 were treated topic-
ally with indoxacarb (19.53% w/w; ACTIVYL®, Merck
Animal Health).
Dogs in group 2 were treated topically with fipronil
(9.8% w/w)–(s)-methoprene (8.8% w/w) spot-on (Front-
line® Plus, Merial) and cats in group 2 were treated top-
ically with fipronil (9.8% w/w)–(s)-methoprene (11.8%
w/w) (Frontline®Plus, Merial).
All pets were weighed prior to each treatment and
products were administered using the commercial prod-
uct applicator. Treatment was administered by parting
the hair with the tip of the applicator and the entire con-
tents were applied directly to the skin in one or more
spots as indicated by the label. While only pets meeting
the inclusion criteria were included in the study for data
collection, all dogs and cats living at a residence or re-
ported to investigators as a visiting pet, were admi-
nistered appropriate treatments. Dogs and cats were
treated once on day 0 and once between days 28 to 30.
All treatments were administered by members of the
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not blinded to treatment groups. No other topical or in-
door premises flea treatments were used during the 60
days of the study. There were no restrictions on the ani-
mals regarding exposure to rain, swimming, or move-
ment outdoors. Owners were asked not to bathe their
pets more than twice a month.
Flea population assessment
The numbers of adult fleas present in the indoor premises
were assessed using intermittent light traps [3-7,14,15].
One trap was placed in each of two rooms for 16 to 24-
hours. Rooms were selected based on where the pet(s)
spent most of the time or where owners had observed
fleas. Once rooms were selected, the traps were returned
to the same rooms in the same location at every counting
period. Fleas collected on the adhesive pads of the traps
were enumerated and identified to species.
The flea population on each pet was assessed using a
visual area count methodology [3-7,16]. Area counts
were performed at five locations on each animal; dorsal
midline, tail head, left lateral, right lateral, and inguinal
region. Area counts were limited to one minute per lo-
cation and conducted by parting the hair against the lay
using both hands until the area was covered. Maximum
number of fleas per zone was capped at 50; therefore the
maximum total area flea counts for a pet was 250. Pet
and premises flea counts were conducted on days 0, 7,
14, 21, 28–30, 40–45, and 54–60. Personnel conducting
pet and premises flea counts were not blinded to treat-
ment groups.
Data analysis
The flea counts in home and flea counts on animal data
were log transformed for analysis. A value of one was
added to all observations to make log transformation ap-
plicable. Data were analyzed for each count day separ-
ately. The log transformed data were analyzed by a
mixed linear model including fixed effect treatment and
random effects home and home* treatment.
Kenward-Roger correction was used to determine the
denominator degrees of freedom. Least squares means
were used for treatment comparisons and were back
transformed to obtain the estimates for the geometric
mean at each week.
The numbers of flea free animals were compared using
Fisher’s exact test.
The null hypothesis is that there is no significant dif-
ference between the two treatment groups. Two tailed
tests were used for the comparison. Statistical signifi-
cance was declared when P ≤ 0.05. The primary software
was SAS version 9.3.
Percentage efficacy achieved by the flea products was
calculated by the following formula: {(Day 0 GeometricMean Flea Counts [pet or trap] - Day x Geometric Mean
Flea Counts [pet or trap])/(Day 0 Geometric Mean Flea
Counts [pet or trap])} multiplied by 100.
Results
Forty-two homes were originally enrolled in the study.
However, three households in the indoxacarb study group
and two households in the fipronil (s)-methoprene group
did not complete the study and therefore data from those
households were not included. In one of the households in
the indoxacarb treatment group, the single enrolled pet was
not at the home to be counted on days 21 or 28 – 30; in
another household in that treatment group one of the dogs
displayed extreme aggressiveness and mauled another dog
in the home; and, in the third home, the owner moved to
another residence one week into the study. In the fipronil
(s)-methoprene treatment group, the only dog on study in
one home displayed extreme aggressiveness one week into
the study, and in the other home the only dog on study
died of a gastric torsion one week into the study. In none of
these cases was product application deemed a cause of
homes and the pets being removed from the study.
In the 18 homes that completed the study where pets
were treated with indoxacarb, there were 32 dogs (avg.
15.4 kg; range 2.1 – 43.0 kg) and 3 cats (avg. 4.4 kg; range
3.1 – 6.3 kg) officially enrolled. On day 0 the dogs re-
ceived a mean topical dose of 22.8 mg/kg (range 15.3 –
47.6 mg/kg) indoxacarb. The cats received a mean topical
dose of 30.1 mg/kg (range 26.1 – 32.2 mg/kg) indoxacarb.
There were an additional 8 dogs and 8 cats in these
homes that did not qualify for the study because they:
had an insufficient numbers of fleas (<5) on day 0, re-
sided permanently outdoors, were brought into the home
after the enrollment date, or could not be safely handled
by flea team members to conduct flea counts. Therefore,
there were a total of 40 dogs and 11 cats resident in the
18 homes that were treated with indoxacarb.
In the 19 homes that completed the study where pets
were treated with fipronil (s)-methoprene there were 30
dogs (avg. 18.7 kg; range 2.1 – 49.6 kg) and 2 cats (avg.
4.6 kg; range 1.6 – 7.7 kg) officially enrolled in the study.
On day 0 the dogs received a mean dose of 12.9 mg/kg
(range 7.2 – 32.8 mg/kg) fipronil and 11.6 mg/kg (range
6.4 – 29.5 mg/kg) (s-)-methoprene. The cats in these
homes received a mean topical dose of 19.0 mg/kg
(range 6.5 – 31.4 mg/kg) fipronil and 22.8 mg/kg (range
7.8 – 37.7 mg/kg) (s)-methoprene. There were an add-
itional 8 dogs and 8 cats in these homes that did not
qualify for the study because of the same factors listed
previously. Therefore, there were a total of 38 dogs and
10 cats resident in the 19 homes that were treated with
fipronil (s)-methoprene.
On day 0, pets in the indoxacarb treatment group had
a geometric mean of 51.0 (range 6 – 250) fleas observed
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prene treatment group had a geometric mean of 28.1
(range 5 – 250) fleas observed in area counts on day 0.
There was one household with 5 dogs in the indoxacarb
treatment group that clearly raised the overall geometric
mean of that treatment group. Four of the dogs met the
upper limit for area counts at 250 fleas per dog and the
other dog had 208 fleas in the area counts. If the area
flea counts from the dogs in that household were elimi-
nated, the geometric mean of the indoxacarb treatment
group would have been 39.2.
Within 7 days of application of indoxacarb or fipronil
(s)-methoprene the flea counts were reduced by 97.8%
and 85.5%, respectively (Table 1). By days 28–30 the flea
counts in the indoxacarb treatment group were reduced
by 95.0% and following reapplication at one month, total
pet flea burden was reduced by 99.1% by days 54–60
(Table 1). Fipronil (s)-methoprene did not reduce flea
populations as effectively, with 49.5% control on day 28–
30 and only 54.8% reduction by days 54 – 60 (P ≤ 0.0079)
(Table 1).
In the indoxacarb treatment group there were signifi-
cantly more flea free pets by the end of the study than in
the fipronil (s)-methoprene treatment group (p < 0.0001)
(Table 1). In the indoxacarb treatment group 77.1% (27/
35) of pets were completely flea free by days 54–60.
Whereas only 15.6% (5/32) of the pets in the fipronil (s)-
methoprene treatment group were flea free by the end
of the study (Table 1).
The client interviews conducted before homes were
entered into the study and again upon completion of the
study provide some interesting insights into pet habits
and outdoor presence of potential flea hosts. Owners re-
ported traveling to other homes with their pet(s) andTable 1 Geometric mean and percent control of on-animal fle
were treated with indoxacarb or fipronil (s)-methoprene base
Treatment group # dogs/cats
Day 0
Indoxacarb2 32/3 Geomean4 51.0a
% control5
% (#) pets with no fleas 0.0
(0/35)
Fipronil (s)-methoprene3 30/2 Geomean 28.1a
% control
% (#) pets with no fleas 0.0
(0/32)
1Dogs and cats treated on day 0 and again between days 28 – 30.
2Dogs and cats were treated topically with indoxacarb (19.53% w/w; ACTIVYL® Merc
3Dogs were treated topically with fipronil (9.8% w/w)–(s)-methoprene (8.8% w/w) sp
(9.8% w/w)–(s)-methoprene (11.8% w/w) (Frontline®Plus; Merial) according to label
4Geometric mean numbers of fleas in visual area counts on pets.
5{(Day 0 geometric mean animal area flea counts – day x geometric mean animal a
a,bGeometric means in a column with unlike letter superscripts are significantly diffehaving other pets visit their homes, sometimes for sev-
eral days. In the indoxacarb and fipronil (s)-methoprene
treatment groups 38.9% (7/18) and 42.1% (8/19) of the
homes had a visitor dog during the study, respectively.
In these cases the investigators were notified and visitor
pets were treated. In the indoxacarb and fipronil (s)-
methoprene treatment groups, dogs from 27.8% (5/18)
and 21.1% (4/19) of the homes visited another home,
however, flea treatment status of pets resident in these
other homes could not be reliably determined.
Potential flea hosts were observed in the immediate
outdoor premises of the homes of pet owners in both
treatment groups. Pet owners in the indoxacarb treat-
ment group said they had seen opossums (77.8%; 14/18),
raccoons (61.1%; 11/18) or feral cats (100.0%; 18/18)
in their yards. The fipronil (s)-methoprene treatment
group was similar with 94.7% (18/19) of pet owners indi-
cating they had seen opossums (68.4%; 13/19), raccoons
(36.8%; 7/19) or feral cats (89.5%; 17/19) in their yards.
During the entire 2 month study, 5,418 fleas were
trapped in the 37 residences using intermittent light
traps and all were identified as Ctenocephalides felis felis,
the cat flea. On day 0, the traps collected a geometric
mean of 29.5 (range 5 – 390) and 25.5 (range 5 – 457)
fleas in homes in the indoxacarb and fipronil (s)-metho-
prene treatment groups, respectively (Table 2). Reduc-
tions in emerging flea populations were 87.9% and 97.7%
by days 28–30 and 54 – 60, respectively in the homes
where pets were treated with indoxacarb (Table 2). Re-
ductions in emerging flea populations were 60.3% and
84.6% by days 28–30 and 54 – 60, respectively in the
homes where pets were treated with fipronil (s)-metho-
prene (Table 2). The geometric mean number of fleas
was significantly lower on post-treatment days 40–45a counts in naturally infested homes when dogs and cats
d topical spot-on formulations
Days post-treatment1
Day 7 Day 14 Day 21 Day 28 – 30 Day 40 - 45 Day 54 - 60
1.1a 0.6a 1.3a 2.6a 0.3a 0.5a
97.8 98.8 97.4 95.0 99.4 99.1
48.6 71.4 40.0 20.0 71.4 77.1
(17/35) (25/35) (14/35) (7/35) (25/35) (27/35)
4.1b 6.4b 13.6b 14.2b 8.0b 12.7b
85.5 77.3 51.5 49.5 71.6 54.8
15.6 15.6 9.4 6.3 21.9 15.6
(5/32) (5/32) (3/32) (2/32) (7/32) (5/32)
k Animal Health) according to label directions.
ot-on (Frontline®Plus; Merial) and cats were treated topically with fipronil
directions.
rea flea counts)/day 0 geometric mean animal area flea counts)} x 100
rent (P values ≤0.0079).
Table 2 Geometric mean and percent control of fleas recovered in premises flea traps in naturally infested homes
when dogs and cats were treated with indoxacarb or fipronil (s)-methoprene based topical spot-on formulations
Treatment group # homes completing study Days post-treatment1
Day 0 Day 7 Day 14 Day 21 Day 28 – 30 Day 40 - 45 Day 54 – 60
Indoxacarb2 18 Geomean4 29.4a 8.1a 5.2a 3.8a 3.5a 0.9a 0.7a
% control5 72.4 82.4 87.2 87.9 97.0 97.7
Fipronil (s)-methoprene3 19 Geomean 25.5a 9.5a 7.5a 7.0a 10.1a 5.1b 3.9b
% control 62.6 70.4 72.4 60.3 79.9 84.6
1Dogs and cats treated on day 0 and again between days 28 – 30.
2Dogs and cats were treated topically with indoxacarb (19.53% w/w; ACTIVYL® Merck Animal Health) accordingly to label directions.
3Dogs were treated topically with fipronil (9.8% w/w)–(s)-methoprene (8.8% w/w) spot-on (Frontline®Plus; Merial) and cats were treated topically with fipronil
(9.8% w/w)–(s)-methoprene (11.8% w/w) (Frontline®Plus; Merial) according to label directions.
4Geometric mean numbers of fleas recovered in two intermittent light flea traps.
5{(Day 0 geometric mean trap flea counts – day x geometric mean trap flea counts)/day 0 geometric mean trap flea counts)} x 100
a,bGeometric means in a column with unlike letter superscripts are significantly different (P values ≤0.0054).
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indoxacarb (p ≤ 0.0054) (Table 2).
During the 2 month study, three households in the
indoxacarb treatment group reported adverse health
events in four dogs. In one household, the owner re-
ported that the dog slept more the night after the first
treatment and would not eat. Upon examination of the
dog the next day, the dog was active, alert and ate when
offered food. In another home the owner reported the
dog “whined” at night following the first treatment, but
the dog was reported as normal the next day. It is un-
known if either of these reports were product related. In
another home both dogs on study vomited during the
night following the first treatment. Neither dog vomited
following the second treatment at one month. The
vomiting episodes in these two dogs may or may not
have been product related. There were no adverse health
events reported in homes where pets were treated with
fipronil (s)-methoprene.
Discussion
The indoxacarb topical spot-on formulation used in this
investigation provided excellent flea control achiev-
ing >99% reductions in pet area counts after two
monthly applications. The residual activity of this formu-
lation was remarkable given the continual reinfestation
pressure from the heavily infested premises. The fipronil
(s)-methoprene topical spot-on formulation did not
eliminate fleas as effectively as the indoxacarb formula-
tion. Following two monthly applications of fipronil (s)-
methoprene the reduction in pet area flea counts was
only 54.8% by the end of the two month study.
The difference in efficacy between the two formula-
tions in this study was further demonstrated when look-
ing at the percent of pets that had no fleas at the end of
the study. Of the pets treated with indoxacarb, 77.1%
were flea free by the end of the 2 month study, whereas
only 15.6% of the pets in the fipronil (s)-methoprene
treatment group were flea free by the end of the study.The level of efficacy observed in this study for the fipro-
nil based topical spot-on was less than that observed pre-
viously in Tampa using the same study design. In 1997 the
percent reduction in pet flea counts after two monthly ap-
plications of a fipronil only based topical spot on was
99.2% by day 60 [4]. In 2009 and 2010 the same fipronil
(s)-methoprene topical spot-on formulation that was used
in the current study was evaluated and the reduction in
pet flea counts by day 60 were 87.5% and 95.5%, respect-
ively [6,7]. It is unknown why two treatments with the
fipronil (s)-methoprene combination did not effectively
eliminate flea infestations on pets in this current study.
The reduced efficacy of the fipronil formulation could be
the result of resistance, innately tolerant flea strains or po-
tentially other factors as yet unknown.
The area count technique used in this and previous in-
home investigations has been shown to detect an average
of 23.5% of the total pet flea burden [16]. Therefore, aver-
age pretreatment total body flea burdens of pets in the
indoxacarb and fipronil (s)-methoprene treatment groups
based on geometric means area counts of 51.0 and 28.1
can be estimated to be approximately 217 and 119 for pets
in this study, respectively. These are remarkably high flea
burdens and it is particularly interesting that the geomet-
ric mean area flea counts observed in this study for pets in
the indoxacarb treatment group were higher than in any
previously published studies these investigators have con-
ducted in Tampa. Prior to this study, the geometric mean
pet counts recorded in 2010 had been the highest at 28.5
[7]. It is unknown why pet flea counts in the 2010 and
2013 studies were higher than in previous years in Tampa.
Factors that might affect flea numbers include: annual dif-
ferences in temperature or humidity, treatment history,
number of pets in a household, number of indoor-outdoor
pets, household air conditioning, and outdoor flea reser-
voir populations.
It is notable that in both treatment groups in the
current study there were dogs whose flea infestation
levels met or exceeded our maximum pet area count of
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ation levels above 50 in a specific region cannot be reli-
ably counted. Based on the area count methodology
employed (23.5% of the total pet flea burden) and previ-
ous investigations conducted by these authors, those
pets where all 5 body areas examined met or exceeded
50 fleas are actually infested with over 1,000 fleas.
It is important to note that while the reduction in pet
flea burdens in the indoxacarb treatment group was ≥
95.0% during the first month it was not uncommon to
observe at least some fleas on animals during this post
treatment period (Table 1). While a slight drop in effi-
cacy was observed by the end of the first month, as
would be expected for any residual insecticide, the better
indicator of the reduction in speed of kill of a product
may be more readily observed in the percent of flea free
dogs. From day 14 post-treatment to the end of the first
month, the percent of dogs with 0 fleas dropped from
71.4% to 20.0%. These data represent the observations
that pet owners are likely to make following treatment
of their pets with any insecticide formulation. Pets in
this study were under unceasing reinfestation pressure
from fleas emerging continuously in their homes. As
speed of kill naturally wanes throughout the month fol-
lowing treatment, pet owners will observe more fleas on
their pets. By the end of the two month study, even
though efficacy against on-animal flea burdens on indox-
acarb treated pets was 99.1%, the number of completely
flea free pets was 77.1%.
Previous in-home studies conducted in Tampa have
also demonstrated that percent reductions in total pet
flea burden are often less than 100% even through 90
days of treatment [3-7]. In the 2010 study where pets
were treated with either a dinotefuran-pyriproxyfen or
fipronil (s)-methoprene topical spot-on formulation, only
60.0% and 55.6% of pets were completely flea free by
days 54 – 60 [7].
The residual efficacy of the fipronil (s)-methoprene
formulation was significantly less against the on-animal
flea burdens in this study than the indoxacarb formula-
tion, and therefore an even more dramatic drop off in ef-
ficacy was observed throughout the month following
application. Efficacy of the fipronil (s)-methoprene for-
mulation fell from 85.5% on day 7 to 49.5% on day 30
post-treatment. Correspondingly, the percent of pets
with 0 fleas fell from 15.6% on day 7 to 6.3% on day 30.
These studies over several years document that it
should be expected to see fleas on some treated pets for
2 to 3 months following treatment. This is particularly
evident in areas with naturally high levels of flea infesta-
tions. Data on the percent of flea free pets post-
treatment in a multicentric study conducted in Europe
are similarly informative [2]. In that study, data from
Spain, a country with a high initial flea infestation rate,demonstrated that 70.3-72.7% of dogs and cats were flea
infested on day 0. Whereas after two monthly applica-
tions of fipronil (s)-methoprene, 33.3%-34.6% of dogs
and cats, still had fleas.
The intermittent-light flea traps used in these in-home
investigations provide an estimate of development and
flea emergence in a home. Following two monthly appli-
cations of indoxacarb or fipronil (s)-methoprene topical
spot-on formulations to the pets, premises flea counts
were reduced by 97.7% and 84.6% respectively. A previ-
ous laboratory study demonstrated that a single topical
spot-on treatment of indoxacarb to cats eliminated or
dramatically reduced egg production and reduced the
viability of the few eggs that were produced for up to 6
weeks after treatment [13]. Given the effect of indoxa-
carb on adult fleas, flea egg production and egg viability,
the 97.7% reduction in emerging flea populations ob-
served in this in-home investigation indicates that
indoxacarb greatly reduced viable flea reproduction
under these tough field conditions.
The efficacy of indoxacarb against fleas infesting pets
and fleas emerging in these homes was similar, but that
was not observed for the fipronil (s)-methoprene formula-
tion. The flea population reductions in premises at the
end of the study in homes with fipronil (s)-methoprene
treated pets were almost 30 percent higher than reduc-
tions in on-animal flea counts. While it is difficult to draw
any definite conclusions, these authors speculate that the
ovicidal activity of the (s)-methoprene on eggs laid by fleas
on treated pets may account for this observation.
A challenge for many pet owners and their pets is the
flea reinfestation pressure from flea infested urban wildlife
as well as dogs and cats. In North America, feral cats and
urban wildlife such as opossums and raccoons can be
infested with Ctenocephalides felis, which can deposit flea
eggs and contaminate protected outdoor premises such as
crawlspaces, decks, and under bushes [1]. Given the po-
tential for reinfestation, it should be of concern that 94.6%
of pet owners in this study had seen feral cats and 73.0%
also reported observing either opossums or raccoons in
their yards. Opossums and raccoons are naturally noctur-
nal; therefore the true number of owners’ yards frequented
by wildlife is likely much higher. Given that such a large
percentage of owners’ yards are frequented by potentially
flea infested animals, it is understandable that dogs and
cats in this subtropical climate face substantial and con-
tinuous flea infestation pressure. These pets need to be on
year-round and life-long flea control, otherwise re-
infestation of the home is almost certain [17].
Another important aspect of this study is that investi-
gators entered homes repeatedly over the two month
study. This afforded investigators the opportunity to
have repeated interaction with pet owners to ascertain
whether other pets were brought into the home and
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On average 40.5% of homes had dogs visit during the
study. Clearly this could be problematic if those dogs
were infested with fleas and then deposited eggs into the
home. In this study we attempted to account for such
occurrences by making sure that visitor dogs were
treated with group appropriate treatments. However,
there could still have been other visitor pets that were
not identified during the study. Veterinary practitioners
need to consider that these visitor pets could contribute
to perceived failure of a prescribed flea control program.
Conclusions
This in-home investigation conducted during the summer
of 2013 in subtropical Tampa, FL is the first published US
field investigation of a novel indoxacarb based topical for-
mulation. In this investigation the indoxacarb formulation
outperformed a fipronil (s)-methoprene formulation and
was able to effectively control flea populations in homes
and on pets even though these pets had the largest natural
flea burdens these investigators had ever recorded in
Tampa FL. The efficacy achieved by the fipronil (s)-meth-
oprene formulation against flea infestations on these pets
was lower than in previous investigations in this area
using the same study design.
This study was conducted without a placebo control
group. While the use of a non-treated group might have
provided a better evaluation of the performance of the
two treatment regimens, it is the opinion of these authors
that the massive flea infestations commonly encountered
in Tampa, FL preclude the use of a non-treated group.
Withholding treatment would be detrimental to the health
and welfare of the dogs, cats and potentially even to
humans in a household.
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